-
(单词翻译:双击或拖选)
By Carolyn Weaver1
Kampala, Uganda
03 May 2006
watch Drug Resistance report
Anti-microbial resistance -- germs becoming resistant2 to medicine -- is part of the natural history of infectious disease. No drug can kill every single harmful microbe. A few bugs4 inside a sick person always survive. Over time, these resistant microbes may come to predominate, rendering5 formerly6 effective medicines useless. In Uganda, as in other African countries, the fight against disease is a race against drug resistance.
-------------------------------------------------------
Sister Florence Nawanga grows artemesia near Entebbe
Sister Florence Nawanga is an herbalist at a convent near Entebbe in south-central Uganda. For the last few years, she's been cultivating an herb that's native to China, but that might hold the key to defeating malaria7 in Africa, too. “This is the plant,” she says, pointing to a small fern-like plant she’s seeded in the bush near the convent.
It's called "sweet wormwood," or Artemesia annua, and the drug derived8 from it, artemisinin, is the key ingredient of what is currently the most effective anti-malarial9 medicine. It came into use just as older anti-malarials such as chloroquine and quinine began to fail.
Few Ugandans can afford insecticide-treated mosquito nets for their children
Malaria caused by a mosquito-borne parasite10, kills more than one million Africans each year, most of them young children. Almost everyone in Uganda has had it at one time or another, especially those who can't afford an insecticide-treated mosquito net, a category that includes most Ugandans.
In the Kampala slum of Katanga, a grandmother cares for 11 children without a single mosquito net, administering the older, less effective anti-malaria drugs to the baby. Last week, she says, the medicine failed to save the youngest child in her care.
Children in Kampala’s Katanga slum
Malaria, AIDS/HIV, tuberculosis11 and poverty reinforce each other in Africa, making each more deadly. Doctors say that malarial fevers in an HIV-infected person are likely to bring on full-blown AIDS, and that most African AIDS patients actually succumb12 to tuberculosis. The AIDS virus, too, is becoming resistant to less costly13, first-line anti-retroviral drugs. And doctors note that in all three illnesses, poor people are less likely to complete drug therapies, a major cause of drug resistance.
Dr. Martin Okot-Nwang, head of TB treatment at Kampala’s Mulago Hospital
“Because the patient is interrupted in taking the drugs, the bug3 recovers,” says Dr. Martin Okot-Nwang, who is the head of tuberculosis treatment at Mulago Hospital in Kampala. “And when it recovers, it's definitely not going to be the same bug."
Dr. Okot-Nwang says perhaps the most important way to prevent an even deadlier variant14 -- multiple-drug-resistant, or MDR tuberculosis -- is using community-based volunteers to make sure that patients complete their drug regimen even after they feel better. “This means someone in the neighborhood who is trained locally to give the patient TB drugs,” he explains, “and who records on the TB cards as the patient swallows the drugs.”
A resident social worker in Katanga distributes anti-malarials
Community-based workers are also being used to fight malaria. Richard is a social worker who distributes free anti-malaria drugs from Mulago Hospital to his fellow slumdwellers. He shows a reporter the green and red Homapaks, as they’re called: green ones for children from two years to five years, and red for babies aged15 two months to two years. The packs contain the first-line combination treatment of chloroquine and Fansidar (sulfadoxine and pyrimethamine): not as effective now as artemesinin, but far better than nothing.
Ugandan doctors say that increased funding from the rest of the world for combating HIV/AIDS, TB and malaria is making a real difference in Uganda. There is other good news: recently, researchers at the University of California at Berkeley announced they have grown a purer form of artemisinin in the laboratory, using yeast16 cells. This synthetic17 form could be the basis for a low-cost combination treatment, lifting the burden of malaria from African peoples and economies. But scientists also warn that if artemisinin is not used correctly as part of a drug-combination cocktail18, the malaria parasite will quickly become resistant to it as well.
1 weaver | |
n.织布工;编织者 | |
参考例句: |
|
|
2 resistant | |
adj.(to)抵抗的,有抵抗力的 | |
参考例句: |
|
|
3 bug | |
n.虫子;故障;窃听器;vt.纠缠;装窃听器 | |
参考例句: |
|
|
4 bugs | |
adj.疯狂的,发疯的n.窃听器( bug的名词复数 );病菌;虫子;[计算机](制作软件程序所产生的意料不到的)错误 | |
参考例句: |
|
|
5 rendering | |
n.表现,描写 | |
参考例句: |
|
|
6 formerly | |
adv.从前,以前 | |
参考例句: |
|
|
7 malaria | |
n.疟疾 | |
参考例句: |
|
|
8 derived | |
vi.起源;由来;衍生;导出v.得到( derive的过去式和过去分词 );(从…中)得到获得;源于;(从…中)提取 | |
参考例句: |
|
|
9 malarial | |
患疟疾的,毒气的 | |
参考例句: |
|
|
10 parasite | |
n.寄生虫;寄生菌;食客 | |
参考例句: |
|
|
11 tuberculosis | |
n.结核病,肺结核 | |
参考例句: |
|
|
12 succumb | |
v.屈服,屈从;死 | |
参考例句: |
|
|
13 costly | |
adj.昂贵的,价值高的,豪华的 | |
参考例句: |
|
|
14 variant | |
adj.不同的,变异的;n.变体,异体 | |
参考例句: |
|
|
15 aged | |
adj.年老的,陈年的 | |
参考例句: |
|
|
16 yeast | |
n.酵母;酵母片;泡沫;v.发酵;起泡沫 | |
参考例句: |
|
|
17 synthetic | |
adj.合成的,人工的;综合的;n.人工制品 | |
参考例句: |
|
|
18 cocktail | |
n.鸡尾酒;餐前开胃小吃;混合物 | |
参考例句: |
|
|